Genflow Biosciences plc (LON: GENF)
London
· Delayed Price · Currency is GBP · Price in GBX 2.000
-0.050 (-2.44%)
Jan 23, 2025, 2:32 PM BST
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 7.17 million as of January 23, 2025. Its market cap has increased by 48.54% in one year.
Market Cap
7.17M
Enterprise Value
6.03M
Revenue
598.04K
Ranking
n/a
PE Ratio
n/a
Stock Price
2.02
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 7.17M, a decrease of -78.69%. That is a compound annual growth rate of -40.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 7.17M | 18.84% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 1.99B |
| Oxford Nanopore Technologies | 1.42B |